Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.48 USD | -0.16% | -3.85% | +3.74% |
04-01 | Liquidia Says US FDA Cleared to Approve Yutrepia to Treat Hypertension | MT |
04-01 | Liquidia's Yutrepia Cleared for Potential FDA Approval Following Court Ruling | DJ |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.74% | 955M | |
+32.36% | 698B | |
+26.51% | 568B | |
-4.40% | 358B | |
+19.46% | 328B | |
+3.50% | 283B | |
+16.34% | 238B | |
+6.68% | 203B | |
-9.08% | 198B | |
+8.62% | 165B |
- Stock Market
- Equities
- LQDA Stock
- News Liquidia Corporation
- Transcript : Liquidia Corporation, 2023 Earnings Call, Mar 13, 2024